"Η Euromedica Γενική Κλινική Θεσσαλονίκης βρίσκεται σε 24ωρη ετοιμότητα, με 247 κλίνες σε 7 ορόφους για κάθε επείγον περιστατικό. Νοσηλεύει κάθε ασθενή με ανθρώπινο, προσωπικό ενδιαφέρον αλλά και τεχνολογία αιχμής. Έχει καθιερωθεί στις συνειδήσεις ως ένας από τους πρωταγωνιστές στον κλάδο της υγείας για όλη τη Βόρειο Ελλάδα."

During the past decade, Euromedical General Clinic of Thessaloniki; Oncology Department conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 20 clinical trials were completed, i.e. on average, 40.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 15 clinical trials were completed. i.e. 53.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Euromedical General Clinic of Thessaloniki; Oncology Department" #1 sponsor was "Hoffmann-La Roche" with 20 trials, followed by "Eli Lilly and Company" with 10 trials sponsored, "Hellenic Cooperative Oncology Group" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Euromedical General Clinic of Thessaloniki; Oncology Department" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "BeiGene" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Euromedical General Clinic of Thessaloniki; Oncology Department" are "Breast Cancer" (10 trials), "Breast Neoplasms" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Type 2 Diabetes Mellitus" (3 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Euromedical General Clinic of Thessaloniki; Oncology Department" in a lesser frequency.

Most popular intervention types in "Euromedical General Clinic of Thessaloniki; Oncology Department" are "Drug" (53 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Atezolizumab" (9 trials), "Paclitaxel" (7 trials), "Docetaxel" (6 trials) and "Fulvestrant" (5 trials). Other intervention names were less common.

The vast majority of trials in "Euromedical General Clinic of Thessaloniki; Oncology Department" are 51 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Euromedical General Clinic of Thessaloniki; Oncology Department". undefined are not yet recruiting, 18 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Euromedical General Clinic of Thessaloniki; Oncology Department, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Euromedical General Clinic of Thessaloniki; Oncology Department, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".